Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
2020 · Cell Reports Medicine · 541 citations
https://doi.org/10.1016/j.xcrm.2020.100040
C
Carl W. Davis
Emory University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
5.8K
Citations
31
h-index
36
i10-index
Carl W. Davis is an academic researcher from Emory University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Viral Infections and Outbreaks Research & Influenza Virus Research Studies. The author has an h-index of 31, co-authored 51 publications.
ORCID: 0000-0002-6049-0684Papers by this author
worksLongitudinal Analysis of the Human B Cell Response to Ebola Virus Infection
2019 · Cell · 185 citations
https://doi.org/10.1016/j.cell.2019.04.036
In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model
2018 · Cell Reports · 50 citations
https://doi.org/10.1016/j.celrep.2018.10.062
Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP(1,2) in a position elevated from the virion membrane
2025 · Nature Communications · 3 citations
https://doi.org/10.1038/s41467-025-56452-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat